HAEMOPHILUS INFLUENZAE

Clinical trials for HAEMOPHILUS INFLUENZAE explained in plain language.

Never miss a new study

Get alerted when new HAEMOPHILUS INFLUENZAE trials appear

Sign up with your email to follow new studies for HAEMOPHILUS INFLUENZAE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Can a new vaccine stop a Lesser-Known bacterial threat?

⭐️ VACCINE ⭐️ Ongoing

This phase 2 trial is testing an experimental vaccine designed to protect against Haemophilus influenzae type a (Hia), a bacterium that can cause serious infections. Healthy adults aged 18 to 65 will be randomly assigned to receive either the vaccine or a placebo. The main goals …

Matched conditions: HAEMOPHILUS INFLUENZAE

Phase: PHASE2 • Sponsor: InventVacc Biologicals Inc. • Aim: ⭐️ VACCINE ⭐️

Last updated Aug 05, 2026 00:00 UTC

HAEMOPHILUS INFLUENZAE

Get alerted when new HAEMOPHILUS INFLUENZAE trials appear

Can a new vaccine stop a Lesser-Known bacterial threat?